Jaguar Animal Health, Inc. (NASDAQ: JAGX) Given Company Update by Aegis Capital Corp.
Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://nnw.fm/8Jn4H). The company has been offered a ‘Buy’ rating with a price target of $10 per share. The company update was announced after JAGX made several decisions that Aegis believes could improve the outlook for the company. The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent…







